Search

Your search keyword '"Sirimarco, Gaia"' showing total 21 results
Start Over Author "Sirimarco, Gaia" Publisher lippincott williams & wilkins
21 results on '"Sirimarco, Gaia"'

2. Association of Time of Day When Endovascular Therapy for Stroke Starts and Functional Outcome.

Author

Hajdu, Steven D., Kaesmacher, Johannes, Michel, Patrik, Sirimarco, Gaia, Knebel, Jean-Francois, Bartolini, Bruno, Kurmann, Christoph C., Puccinelli, Francesco, Mosimann, Pascal J., Bonvin, Christophe, Arnold, Marcel, Niederhäuser, Julien, Eskandari, Ashraf, Mordasini, Pasquale, Gralla, Jan, Fischer, Urs, Saliou, Guillaume, Michel, Prof Patrik, Arnold, Prof Marcel, and Gralla, Prof Jan

Published
2021
Full Text
View/download PDF

5. A tool to identify patients with embolic stroke of undetermined source at high recurrence risk.

Author

Ntaios, George, Georgiopoulos, Georgios, Perlepe, Kalliopi, Sirimarco, Gaia, Strambo, Davide, Eskandari, Ashraf, Nannoni, Stefania, Vemmou, Anastasia, Koroboki, Eleni, Manios, Efstathios, Rodrıguez-Campello, Ana, Cuadrado-Godia, Elisa, Roquer, Jaume, Arnao, Valentina, Caso, Valeria, Paciaroni, Maurizio, Diez-Tejedor, Exuperio, Fuentes, Blanca, Pardo, Jorge Rodrıguez, and Sanchez-Velasco, Sara

Published
2019
Full Text
View/download PDF

9. Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source.

Author

Ntaios, George, Lip, Gregory Y.H., Lambrou, Dimitris, Michel, Patrik, Perlepe, Kalliopi, Eskandari, Ashraf, Nannoni, Stefania, Sirimarco, Gaia, Strambo, Davide, Vemmos, Konstantinos, Koroboki, Eleni, Manios, Efstathios, Vemmou, Anastasia, Rodríguez-Campello, Ana, Cuadrado-Godia, Elisa, Roquer, Jaume, Arnao, Valentina, Caso, Valeria, Paciaroni, Maurizio, and Diez-Tejedor, Exuperio

Published
2018
Full Text
View/download PDF

19. Is Intracerebral Hemorrhage a Time-Dependent Phenomenon After Successful Combined Intravenous and Intra-Arterial Therapy?

Author

Mosimann, Pascal J., Sirimarco, Gaia, Meseguer, Elena, Serfaty, Jean-Michel, Laissy, Jean-Pierre, Labreuche, Julien, Lapergue, Bertrand, Gonzalez-Valcarcel, Jaime, Lavallée, Philippa C., Cabrejo, Lucie, Guidoux, Celine, Klein, Isabelle F., Olivot, Jean-Marc, Schouman-Claeys, Elisabeth, Amarenco, Pierre, and Mazighi, Mikael

Published
2013
Full Text
View/download PDF

21. Outcomes after thrombolysis in AIS according to prior statin use: a registry and review.

Author

Meseguer E, Mazighi M, Lapergue B, Labreuche J, Sirimarco G, Gonzalez-Valcarcel J, Lavallée PC, Cabrejo L, Guidoux C, Klein IF, Olivot JM, Rouchaud A, Desilles JP, and Amarenco P

Subjects
Aged, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors administration & dosage, Male, Middle Aged, Treatment Outcome, Brain Ischemia drug therapy, Hydroxymethylglutaryl-CoA Reductase Inhibitors adverse effects, Registries, Stroke drug therapy, Thrombolytic Therapy methods
Abstract

Background: The impact of prior statin use on outcomes after thrombolysis is unclear. We evaluated outcomes of patients treated by IV, intra-arterial (IA) thrombolysis, or combined therapy, according to prior statin use., Methods: We analyzed data from a patient registry (606 patients) and conducted a systematic review., Results: We identified 11 previous studies (6,438 patients) that evaluated the effect of statin use on outcomes after IV thrombolysis (8 studies), IA thrombolysis (2 studies), or a single/combined approach (1 study). In our registry and in most of the retrieved studies, statin users had more risk factors and concomitant antiplatelet treatment than nonstatin users. Regardless of treatment strategy, prior statin use was not associated with favorable outcome (adjusted odds ratio [OR] 1.36; 95 confidence interval [CI] 0.86-2.16), symptomatic intracranial hemorrhage (sICH) (OR 0.57; 95% CI 0.22-1.49), or recanalization (OR 1.87; 95% CI 0.69-5.03). In meta-analysis, prior statin use was not associated with favorable outcome (crude OR 0.99; 95% CI 0.88-1.12), but was associated with an increased risk of sICH (crude OR 1.55; 95% CI 1.23-1.95). However, when the available multivariable associations were combined (5 studies), the effect of prior statin use on risk of sICH was not significant (OR 1.31; 95% CI 0.97-1.76)., Conclusions: These results suggest no beneficial or detrimental effect of prior statin use in acute stroke patients treated by IV thrombolysis, IA thrombolysis, or combined therapy, although the numbers of patients treated by IA thrombolysis or combined therapy are too small to exclude an effect.

Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results